Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) said Wednesday that it has formed a strategic partnership with biotechnology company Endocanna Health Inc to sell its endocannabinioid DNA test kits through its cannabis healthcare clinics.
In a statement, the company said Los Angeles-based Endocanna Health , a partly-owned subsidiary of Heritage Cannabis (CSE:CANN), will make its patent-pending endocannabinoid DNA test kits for Empower.
It will also license its proprietary DNA technology to Seattle-based Empower Clinics which operates a network of medical cannabis healthcare clinics in Washington State, Oregon, Arizona, Illinois and Nevada. The physician-staffed clinics focus on helping nearly 165,000 patients through the use of medical cannabis.
Empower said it plans to include the EndoDNA test kits as a “standard offering” through its Sun Valley Health franchise program and has immediately started the roll-out in the United States.
"The Endocanna DNA test kit can give our physicians the potential to have even greater insight into each individual patient's propensity for success, on how CBD based therapies may interact with their individual regulatory system," said Empower Clinics CEO Steven McAuley in a statement.
McAuley said the strategic tie-up is geared towards getting patients the best care and advice using the “most advanced technology” available.
The kits are designed to provide consumers with personalized data on how CBD and other cannabinoids may interact with their body. The technology allows the company to provide patients with science-backed cannabis product suggestions based on their specific DNA.
For most of history, the effects of cannabis on the human body were little understood. Then, in the 1990s, scientists discovered endocannabinoids, the natural cannabis-like molecules produced by the human body. It appears the main function of the endocannabinoid system is to regulate a variety of physiological and cognitive processes including appetite, pain-sensation, mood, and memory.
Endocanna Health co-founder and CEO Len May said that by using the DNA report, Empower can provide a “cannabinoid wellness protocol” tailored to each patient's individual needs.
“Empower and their Sun Valley Health clinic network, provides an immediate opportunity for us to work with physicians and patients to develop advanced science surrounding the endocannabinioid system and CBD based therapies," May added.
Contact Uttara Choudhury at email@example.com
Follow her on Twitter: @UttaraProactive